Activities
The Pharmacist's Role in Managing Immune-Related Adverse Events Associated with Immuno-Oncology Therapies
0290-0000-19-002-L05-P
1-22-2019
1.00
An American Journal of Managed Care Webinar: The Clinical and Managed Care Implications of X-Linked Hypophosphatemia
0290-0000-18-232-H01-P
This webinar will provide an overview of the pathophysiology and clinical presentation of XLH, current and emerging treatment options, and managed care implications.
1.00
An American Journal of Managed Care Medical Crossfire: A Payer and Neurologist Discussion on the Shifting Paradigm of Alzheimer's Disease Treatment
0290-0000-18-228-H01-P
During this AJMC Medical Crossfire, expert faculty will facilitate discussion of the pathophysiology and outcomes of AD and discuss disease-modifying treatments.
1.50
An American Journal of Managed Care Payer and Specialty Pharmacy Forum: Clinical Updates and Outcomes Data for PCSK9 Inhibitors
0290-0000-18-223-H01-P
This activity will highlight which patients benefit the most from treatment with a PCSK9 inhibitor to ensure these medications are used most effectively.
1.50